{"id":246,"date":"2026-08-15T05:03:35","date_gmt":"2026-08-15T05:03:35","guid":{"rendered":"https:\/\/dentaltransitions.com\/articles\/dso-affiliation-options-cleveland\/"},"modified":"2026-08-15T05:03:35","modified_gmt":"2026-08-15T05:03:35","slug":"dso-affiliation-options-cleveland","status":"publish","type":"post","link":"https:\/\/dentaltransitions.com\/articles\/dso-affiliation-options-cleveland\/","title":{"rendered":"DSO Affiliation Options in Cleveland for $1.5M+ Practices"},"content":{"rendered":"<h2>Key Takeaways for Cleveland Practice Owners<\/h2>\n<ul>\n<li>\n<p>Cleveland-area practices generating $1.5 M+ in revenue face a competitive buyer landscape that includes national DSOs, regional platforms, and specialty groups actively acquiring in Northeast Ohio.<\/p>\n<\/li>\n<li>\n<p>Valuations are often based on adjusted EBITDA multiples rather than gross revenue, with 2026 offers commonly ranging from 6\u00d7 to 12\u00d7 depending on practice quality and provider transition risk.<\/p>\n<\/li>\n<li>\n<p>Deal structures typically combine 60\u201375% cash at close, 10\u201330% equity rollover, and an earnout component, so equity tier and post-close performance targets usually deserve close review.<\/p>\n<\/li>\n<li>\n<p>Clinical autonomy after affiliation is shaped by contract terms covering employment length, production targets, vendor standardization, staff continuity, and non-compete clauses.<\/p>\n<\/li>\n<li>\n<p>McLerran &amp; Associates provides side-by-side valuations and buyer vetting for both DSO and private-buyer pathways; <a target=\"_blank\" rel=\"noopener noreferrer nofollow\" href=\"https:\/\/dentaltransitions.com\/contact-us\/\">schedule a confidential discovery call<\/a> to explore your options.<\/p>\n<\/li>\n<\/ul>\n<h2>Who Is Buying Practices in Cleveland Right Now<\/h2>\n<p>Acquisition activity in Ohio has accelerated meaningfully in 2025\u20132026. <a target=\"_blank\" rel=\"noindex nofollow\" href=\"https:\/\/beckersdental.com\/dso-dpms\/130-dso-affiliations-so-far-in-2026-state-by-state-breakdown\">Multiple national and regional groups completed Ohio affiliations in early 2026<\/a>, including a Midwest-based group entering the state for the first time and a Chicago-based specialty platform adding a multi-site orthodontic practice as its first Ohio deal. Most notably for the Cleveland market, <a target=\"_blank\" rel=\"noindex nofollow\" href=\"https:\/\/aol.com\/articles\/specialty1-partners-expands-ohio-joint-200800000.html\">a Houston-based specialty group announced a joint venture with a premier periodontal and implant practice serving greater Cleveland in July 2026<\/a>, expanding its Ohio presence to three partner practices and seven locations.<\/p>\n<p>Buyer footprints in this market are not uniform. The table below contrasts the two primary buyer categories active in Northeast Ohio, showing how their operational models and equity structures can create very different post-close experiences for owners.<\/p>\n<table style=\"min-width: 100px;\">\n<colgroup>\n<col style=\"min-width: 25px;\">\n<col style=\"min-width: 25px;\">\n<col style=\"min-width: 25px;\">\n<col style=\"min-width: 25px;\"><\/colgroup>\n<tbody>\n<tr>\n<th colspan=\"1\" rowspan=\"1\">\n<p>Dimension<\/p>\n<\/th>\n<th colspan=\"1\" rowspan=\"1\">\n<p>National Buyers<\/p>\n<\/th>\n<th colspan=\"1\" rowspan=\"1\">\n<p>Regional \/ Specialty Buyers<\/p>\n<\/th>\n<th colspan=\"1\" rowspan=\"1\">\n<p>What It Means for You<\/p>\n<\/th>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Geographic reach<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>20+ states, standardized playbook<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>1\u20135 states, market-specific approach<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>National buyers often move faster, regional buyers may offer more flexibility<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Integration model<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Centralized systems, branded or co-branded<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Often partnership or JV model, local brand retention more common<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Brand and staff continuity terms can vary widely by buyer type<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Equity structure<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Typically holding-company equity, higher ceiling, no distributions<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Often JV-level equity, distributions more common, lower ceiling<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Equity tier influences how your retained stake grows, or fails to grow<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Recapitalization timeline<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Many buyers anticipate a recap within 12\u201336 months<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Varies, earlier-stage platforms may recap sooner<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Timing your sale ahead of a recap can create meaningful negotiating leverage<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The buyer universe is larger than many owners expect. Seeing only one or two of those buyers, which is common when an owner goes it alone, can leave most of the competitive tension unused.<\/p>\n<p><a target=\"_blank\" rel=\"noopener noreferrer nofollow\" href=\"https:\/\/dentaltransitions.com\/contact-us\/\">Learn which buyers are actively acquiring in the Cleveland market right now by scheduling a confidential discovery call<\/a>.<\/p>\n<h2>How EBITDA-Based Valuation Works for Larger Practices<\/h2>\n<p>Buyers often price practices on a multiple of adjusted EBITDA, not gross revenue. Adjusted EBITDA adds back discretionary, personal, and non-recurring expenses to estimate the practice\u2019s true economic output. The multiple applied to that number usually determines your headline offer.<\/p>\n<p>Practices with adjusted EBITDA in the $1 million\u2013$3 million range have traded at varying multiples in 2026, while offer dispersion has widened significantly, with valuations commonly ranging from 6\u00d7 to 12\u00d7 EBITDA depending on practice size, quality, provider transition risk, and reimbursement exposure. Factors that can move a practice toward the upper end of that range include hygiene revenue representing 30\u201335% of total production, a diversified payer mix, technology infrastructure, and multi-location scale.<\/p>\n<p>Because these factors are open to interpretation, the valuation analysis itself is where most of the damage or most of the upside can be determined quietly. A \u201cfree\u201d back-of-the-napkin number set by the buyer often becomes the anchor for the entire negotiation. McLerran &amp; Associates builds a CPA-led, diligence-grade EBITDA analysis before the practice goes to market, unpacking every add-back so the number tends to hold when buyers scrutinize it. The result: McLerran\u2019s clients have historically achieved approximately 30% higher valuations than owners who sell on their own, and the firm reports a transaction rate of roughly 85\u201390%, compared to an industry norm closer to 35\u201340%.<\/p>\n<figure style=\"text-align: center;\"><img src=\"https:\/\/cdn.aigrowthmarketer.co\/1782231605342-03c5ed4725a3.jpeg\" alt=\"At McLerran &amp; Associates, every engagement is built on an ironclad, CPA-led EBITDA analysis and practice valuation.\" style=\"max-height: 500px;\" loading=\"lazy\" decoding=\"async\"><figcaption><em>At McLerran &amp; Associates, every engagement is built on an ironclad, CPA-led EBITDA analysis and practice valuation.<\/em><\/figcaption><\/figure>\n<h2>How Cash, Equity, and Earnouts Work in Cleveland Deals<\/h2>\n<p>Affiliation deals are rarely all-cash, so understanding each component can help you compare offers more clearly.<\/p>\n<p>Typical affiliation deals are structured with cash at close representing 60\u201375% of total consideration, equity rollover into the platform ranging from 10\u201330%, and an earnout component tied to hitting EBITDA targets in the 12\u201336 months after closing. An earnout is a deferred payment contingent on future performance, which rewards the seller if the practice hits agreed profit targets post-close.<\/p>\n<p>The equity portion usually deserves particular scrutiny. Equity can be held at two levels:<\/p>\n<ul>\n<li>\n<p><strong>Joint-venture (JV) level:<\/strong> Equity in the local operating entity. Distributions are more common, which can provide a higher income floor, but the ceiling on appreciation is often lower.<\/p>\n<\/li>\n<li>\n<p><strong>Holding-company level:<\/strong> Equity in the parent platform. Regular distributions are uncommon, but the stake can multiply several times over at a future recapitalization event.<\/p>\n<\/li>\n<\/ul>\n<p>As much as 40% of a deal can be paid in equity rather than cash, so the seller is effectively buying stock in the platform and may want to underwrite it as carefully as any investment. McLerran &amp; Associates models real after-tax outcomes across all three components over 3-, 5-, 7-, and 10-year horizons, including conservative recapitalization assumptions, so owners can compare what each deal is actually worth, not just the headline number.<\/p>\n<h2>Clinical Autonomy and Contract Terms After Affiliation<\/h2>\n<p>Clinical autonomy after affiliation can remain real, but it is usually bounded by structure and contract language. Under the model, a dentist-owned professional corporation retains ownership of the clinical practice and holds the dental license, while the platform provides non-clinical services via a long-term management services agreement. In daily practice, the affiliated dentist retains authority over diagnosis and treatment planning, but <a target=\"_blank\" rel=\"noindex nofollow\" href=\"https:\/\/curvedental.com\/dental-blog\/dso-vs-dental-group-practice-difference\">influence can extend into scheduling pace, production targets, preferred vendor lists, software platforms, and the treatment environment even when formal clinical decision rights remain with the dentist<\/a>.<\/p>\n<p>Key contract realities to evaluate before signing include:<\/p>\n<ul>\n<li>\n<p><strong>Employment term:<\/strong> Groups commonly require a five-year post-close employment term, with provider continuity becoming a top reason deals are terminated when not secured. That commitment can feel more binding when combined with production expectations.<\/p>\n<\/li>\n<li>\n<p><strong>Production targets:<\/strong> <a target=\"_blank\" rel=\"noindex nofollow\" href=\"https:\/\/dentaltown.com\/channel\/post\/24750\/private-equity-in-dentistry-how-dsos-impact-dentists\">Compensation models commonly tie dentist pay to production metrics, creating direct financial pressure to increase volume<\/a>. Those metrics are usually tracked through systems you may not control.<\/p>\n<\/li>\n<li>\n<p><strong>Vendor and technology control:<\/strong> <a target=\"_blank\" rel=\"noindex nofollow\" href=\"https:\/\/curvedental.com\/dental-blog\/dso-vs-dental-group-practice-difference\">Groups typically standardize on a single practice management software platform, leaving affiliating dentists with little or no say in technology choices<\/a>. That standardization often extends to your staff\u2019s daily workflows.<\/p>\n<\/li>\n<li>\n<p><strong>Staff continuity:<\/strong> Acquisitions frequently create culture friction between corporate managers and existing staff, increasing the risk of key personnel turnover unless staff are involved in integration planning. Losing key staff can become more likely when you are also restricted from competing locally.<\/p>\n<\/li>\n<li>\n<p><strong>Non-compete clauses:<\/strong> <a target=\"_blank\" rel=\"noindex nofollow\" href=\"https:\/\/dentaltown.com\/channel\/post\/24750\/private-equity-in-dentistry-how-dsos-impact-dentists\">Many affiliation contracts contain geographic non-compete clauses that can prevent a selling dentist from opening a new practice in the same community for years after the transaction<\/a>.<\/p>\n<\/li>\n<\/ul>\n<p>Autonomy outcomes can vary materially by buyer. McLerran &amp; Associates vets buyers like investments, steering clients away from groups known for poor post-close environments and toward well-backed, well-run partners with a track record of satisfied sellers.<\/p>\n<h2>Choosing Between DSO Affiliation and Private Sale<\/h2>\n<p>For practices in the $1.5\u20133 million revenue range, both pathways are genuinely available. The right answer can depend on the owner\u2019s goals, timeline, and practice profile rather than a predetermined preference for one path.<\/p>\n<p>A side-by-side comparison of the two primary outcomes can help clarify tradeoffs.<\/p>\n<p><strong>Affiliation<\/strong> can deliver a higher total consideration figure, particularly for practices with strong EBITDA margins. General dental practices with $1.5 million\u2013$5 million in collections can command the upper end of the EBITDA multiple range discussed earlier when they demonstrate strong margins and operational quality. The tradeoff often includes a multi-year employment commitment, reduced operational autonomy, and equity risk tied to the platform\u2019s future performance.<\/p>\n<p><strong>Doctor-to-doctor (private buyer) sale<\/strong> can offer a cleaner exit, typically a 4\u20138 week work-back, with full legacy control and no retained equity risk. Solo general dental practices selling to private buyers are typically worth 2.5\u00d7\u20135.0\u00d7 SDE, or roughly 60%\u201380% of collections. The tradeoff is a lower headline number and a buyer pool that has become more competitive, as bidder competition has raised bid levels for solo buyers to 65\u201385% of collections.<\/p>\n<p>Because McLerran &amp; Associates works both pathways in roughly equal measure, with approximately 50% of engagements as private-buyer transactions and 50% as affiliations, the firm produces a true side-by-side valuation quantifying a practice\u2019s worth in both markets. Owners in the $1.5\u20133 million middle can then choose their path with fuller information rather than a guess.<\/p>\n<p><a target=\"_blank\" rel=\"noopener noreferrer nofollow\" href=\"https:\/\/dentaltransitions.com\/contact-us\/\">Get a side-by-side valuation for your Cleveland-area practice by scheduling a discovery call with McLerran &amp; Associates<\/a>.<\/p>\n<h2>The Four-Part Journey From Valuation to Closing<\/h2>\n<p><strong>Understand Your Options.<\/strong> Before any buyer conversation begins, a diligence-grade EBITDA analysis establishes the practice\u2019s estimated value in both markets. McLerran &amp; Associates remotely accesses practice management software, cross-references financials, and unpacks every discretionary and non-recurring expense. This process produces a number that many accountants would recognize as high quality and that is less likely to be re-traded when buyers review it.<\/p>\n<p><strong>Create Competition.<\/strong> A structured, auction-like bid process, typically 45\u201360 days, solicits offers from a vetted pool of well-qualified buyers. McLerran\u2019s process typically generates around 10 offers per listing, more than four times that level of competition, with poorly run groups blacklisted before they ever reach the table.<\/p>\n<p><strong>Find the Right Fit.<\/strong> The highest bidder is not always the right buyer. McLerran narrows from initial offers to in-person meetings with the top one to three finalists, evaluating each buyer\u2019s profitability, growth trajectory, management team, and private equity backing. Clinical autonomy expectations can be clarified before exclusivity is granted, rather than after the buyer controls the process.<\/p>\n<figure style=\"text-align: center;\"><img src=\"https:\/\/cdn.aigrowthmarketer.co\/1782231776232-426cf610db07.jpeg\" alt=\"A chat at McLerran &amp; Associates: the dental-specific sell-side advisor and advocate for practice owners guides on how, when, and to whom to sell your practice.\" style=\"max-height: 500px;\" loading=\"lazy\" decoding=\"async\"><figcaption><em>A chat at McLerran &amp; Associates: the dental-specific sell-side advisor and advocate for practice owners guides on how, when, and to whom to sell your practice.<\/em><\/figcaption><\/figure>\n<p><strong>Maximize Your Outcome.<\/strong> After the letter of intent is signed, McLerran provides quality-of-earnings defense, protecting the EBITDA it underwrote when the buyer\u2019s diligence team scrutinizes the numbers, and manages the process through closing. The firm\u2019s transaction rate, noted earlier at roughly 85\u201390%, stands in contrast to a do-it-yourself close rate of approximately 15\u201320%.<\/p>\n<p><a target=\"_blank\" rel=\"noopener noreferrer nofollow\" href=\"https:\/\/dentaltransitions.com\/contact-us\/\">Start this four-part journey with a sell-side advisor who runs both pathways in equal measure by scheduling your discovery call today<\/a>.<\/p>\n<h2>Frequently Asked Questions<\/h2>\n<h3>How active is the DSO buyer market in Cleveland and Northeast Ohio right now?<\/h3>\n<p>The Cleveland and Northeast Ohio market has seen meaningful DSO activity in 2025\u20132026, with national platforms, regional groups, and specialty-focused buyers all completing affiliations in the state. The buyer universe nationally spans more than 135 DSOs and private equity groups, and a significant share of those buyers are actively evaluating Midwest markets. For owners of $1.5 million-plus practices, the current environment, characterized by high demand and relatively low supply of premium practices, can represent a favorable seller\u2019s window. A large share of DSO buyers also anticipate a recapitalization event within the next 12\u201336 months, which can create additional urgency to complete acquisitions ahead of those timelines.<\/p>\n<h3>What happens to my staff and patients after a DSO affiliation?<\/h3>\n<p>Staff and patient continuity outcomes can vary significantly depending on which DSO you affiliate with and how the contract is structured. Some DSOs use a partnership model that allows the practice to retain its local name and many existing workflows, while others require adoption of a corporate brand and standardized systems. Non-clinical staff typically become employees of the DSO, which can bring changes to payroll, benefits, and HR policies. The risk of key personnel turnover increases when staff are not involved in integration planning. McLerran &amp; Associates evaluates each buyer\u2019s post-close track record as part of the vetting process and has blacklisted groups known for creating difficult post-close environments, so protecting your staff and patients becomes part of finding the right fit rather than an afterthought.<\/p>\n<h3>Should I sell to a DSO or a private buyer if my practice generates $1.5\u20133 million in revenue?<\/h3>\n<p>Practices in this revenue range sit in what McLerran &amp; Associates calls the \u201cVenn diagram middle,\u201d genuinely able to pursue either pathway. A DSO affiliation can deliver a higher total consideration figure, particularly for practices with strong EBITDA margins and multi-doctor scalability, but it comes with a multi-year employment commitment and retained equity risk. A doctor-to-doctor sale can offer a cleaner, faster exit with full legacy control, though the headline number is typically lower. The right answer can depend on your specific financials, your goals, and your timeline. Because McLerran works both markets in roughly equal measure, the firm produces a true side-by-side valuation, quantifying your practice\u2019s worth in both the private-buyer and DSO markets, so you can choose with fuller information rather than a guess.<\/p>\n<h3>How long does a DSO affiliation process typically take from first conversation to closing?<\/h3>\n<p>The timeline from initial engagement to wire transfer at closing can range from several months to close to a year, depending on the complexity of the practice, the deal structure, and the buyer\u2019s diligence process. McLerran &amp; Associates\u2019 structured bid process typically runs 45\u201360 days from going to market to receiving offers, after which the firm narrows to finalists, negotiates the letter of intent, and manages diligence through closing. Owners may want to plan for a meaningful time commitment and recognize that deals can fall apart at multiple points without an experienced advisor managing the process, which is a primary reason do-it-yourself close rates can run as low as 15\u201320% compared to roughly 80% for a well-run brokered process.<\/p>\n<h2>Conclusion: Why Representation Can Shape Your Outcome<\/h2>\n<p>DSO affiliation options in Cleveland are real, competitive, and more complex than any single buyer is likely to explain. The EBITDA valuation mechanics, deal structures, clinical autonomy realities, and buyer quality differences covered in this guide reflect the landscape as it exists in 2026. It is a market where <a target=\"_blank\" rel=\"noindex nofollow\" href=\"https:\/\/www.oralhealthgroup.com\/dental-industry\/us-dental-practice-sales-2026-1003997582\/\">according to TUSK Practice Sales citing American Dental Association data, the U.S. dental industry is approximately 35 percent consolidated, though definitions of consolidation vary and narrower ADA measures show lower figures<\/a>, leaving substantial runway for well-positioned practices to transact at strong valuations when they approach the process with thoughtful representation.<\/p>\n<p>McLerran &amp; Associates is the nation\u2019s largest dental-specific sell-side M&amp;A advisory firm, with approximately 2,000 successful practice sales, roughly $2 billion in closed transaction volume, and more than 10,000 practices evaluated. The Cleveland office, led by Justin Klingshim, has completed recent closings in Ohio and brings the firm\u2019s full national buyer network and CPA-led valuation process to Northeast Ohio practice owners. McLerran works both the DSO and private-buyer pathways in roughly equal measure, so every client receives a genuine side-by-side comparison before committing to any path.<\/p>\n<p>Considering a transition now or down the road can raise many questions. <a target=\"_blank\" rel=\"noopener noreferrer nofollow\" href=\"https:\/\/dentaltransitions.com\/contact-us\/\">Schedule a confidential discovery call with McLerran &amp; Associates<\/a>. Call <strong>(512) 900-7989<\/strong>, email <strong>info@dentaltransitions.com<\/strong>, or visit the <strong>contact page<\/strong>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Explore DSO affiliation options for Cleveland $1.5M+ practices. McLerran compares offers, valuations &#038; deal structures. Get started today.<\/p>\n","protected":false},"author":1,"featured_media":245,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-246","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/posts\/246","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/comments?post=246"}],"version-history":[{"count":0,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/posts\/246\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/media\/245"}],"wp:attachment":[{"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/media?parent=246"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/categories?post=246"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/tags?post=246"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}